Skip to main content
TOVX
NYSE Life Sciences

Theriva Sets 1-for-30 Reverse Split Effective December 1 to Regain NYSE American Compliance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.119
Mkt Cap
$5.507M
52W Low
$0.12
52W High
$0.492
52W Position info
1.2% below low
Off High info
76% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

TOVX is trading near its 52-week low of $0.12 (1.2% below the low) on light trading volume (0.4× avg).

Summary

Theriva will execute a 1-for-30 reverse split effective December 1, 2026, cutting outstanding shares from 45.9 million to about 1.53 million to satisfy NYSE American's per-share price rule — a compliance move coming days after a going-concern warning and a vote to expand authorized shares.


Key Events · Corporate Governance and Compliance · TOVX

  • 1-for-30 Reverse Split Approved

    The Board authorized the split on November 13, 2026; it takes effect at 11:59 p.m. ET on December 1, 2026, with split-adjusted trading beginning December 2 under ticker TOVX and new CUSIP 87164U607.

  • Share Count Cut to ~1.53 Million

    Outstanding shares drop from 45,892,668 to approximately 1,529,756, and authorized shares fall proportionally from 350,000,000 to 11,666,666 — no net change in authorized headroom.

  • Listing Compliance Is the Stated Driver

    Theriva says the split is being effected to meet the per-share price requirements of the NYSE American, its current listing exchange.

  • Going-Concern Backdrop

    The Q3 10-Q filed November 12 reaffirmed substantial doubt about going concern with $8.5 million of cash funding operations only into Q1 2027, and stockholders approved raising authorized stock to 500,000,000 shares on November 18.


Analysis · TOVX · Life Sciences

Theriva is consolidating its shares 30-to-1 to lift the price above NYSE American's per-share listing threshold — the stock trades at $0.1186, essentially at its 52-week low of $0.12. The split itself creates no value: 45,892,668 shares become roughly 1,529,756, and authorized shares fall from 350,000,000 to 11,666,666, so the proportional reduction preserves the existing share-count headroom rather than adding any. What matters is the backdrop. Management reaffirmed substantial doubt about going concern in the Q3 10-Q filed November 12, with $8.5 million of cash funding operations only into Q1 2027, and stockholders just approved raising authorized stock to 500,000,000 shares on November 18 — a shelf of capacity that a reverse split now re-prices. A split executed from a position of listing weakness, days after a going-concern warning, usually precedes capital raising; the December 1 effective date is the next hard checkpoint.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, TOVX was trading at $0.12 on NYSE in the Life Sciences sector, with a market capitalization of approximately $5.5M. The 52-week trading range was $0.12 to $0.49. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TOVX - Latest Insights

TOVX
Nov 18, 2026, 4:31 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.144
Real-time Price: $0.1013 info
Change: -$0.0427 (-30%) info
Market Cap: $5.507M info
TOVX
Nov 12, 2026, 8:15 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.160
Real-time Price: $0.1013 info
Change: -$0.0587 (-37%) info
Market Cap: $5.507M info
TOVX
Nov 12, 2026, 8:10 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.160
Real-time Price: $0.1013 info
Change: -$0.0587 (-37%) info
Market Cap: $5.507M info
TOVX
Nov 02, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.1802
Real-time Price: $0.1013 info
Change: -$0.0789 (-44%) info
Market Cap: $5.507M info